Sally Church's Library tagged → View Popular
Hematology Market Insights
Market insights and intelligence on the world of blood based products and cancers
Cancer Technologies and Insights
As we learn more about how cancer work, so do the technologies for eradicating them become more sophisticated. Insights into the changing scientific world of cancer.
Oncology Market Trends
A new blog - developments in the science and biology of cancer disease
Oncology Consulting News - Blog
News and views from the cancer arena from Sally
Drugs in the Pipeline: New Therapies that Could Change Treatment Strategies
New drug compounds, and old ones put to new use, offer doctors and patients new hope for treating and preventing cancer.
The Scientist : Heading for the BIG Time [2008-04-01]
Integrating cancer data using bioinformatics... a new cool and interesting approach.
Gleevec Pushes Advanced Melanoma Into Remission
Malignant melanoma is almost impossible to treat and so understanding the biology of the disease may lead to improved therapies. Gleevec is known to target the KIT mutation and so the finding that KIT is mutated in melanoma would make it a logical choice
Gene combo may hike prostate cancer risk
"It also might lead to a blood test to predict who is likely to develop prostate cancer. These men could be closely monitored and perhaps offered hormone-blocking drugs like finasteride to try to prevent the disease."
Ah now that's a bit more like it -
Court declines experimental drugs case
These cases are always sad - there is no evidence that giving drugs to terminally ill cancer patients will cure them. Potentially prolong their life by a few days or weeks, but the end result is likely to be the same. Sometimes, allowing patients to die
Device can spot cancer cells in blood: U.S. study - Yahoo! News
"A highly sensitive microchip may help doctors detect rare traces of cancer circulating in the bloodstream, offering a way to better manage treatment... " Wow! We all know that the earlier you detect and treat cancer, the better the long term overall su
Press Releases - American Society of Hematology
A few years ago, survival from chronic myeloid leukemia was 3-4 years; with new therapies patients are now living 6 years after failure of interferon, so that's about 10 years in total. An incredible improvement!
'Velcade, lenalidomide and dexamethasone combo show promise for multiple myeloma'
New combinations are the way forward in the treatment of cancer - targeting different aspects of the cancer cell may help reduce resistance. For example, the Rev/Vel/Dex combo in myeloma looks very promising indeed.
Cell 'Addiction' to Growth Factors May Help Spur Cancers - Yahoo! News
"It means we might be able to do something about at-risk cells before cancer develops and treat these cells biochemically, and specifically, rather than using current drugs that are nonspecific and kill everything in their path." Now that sounds almost
Graveyard shift work linked to cancer - Yahoo! News
No surprises here, just plain common sense.
Icarus Consultants
Consulting to pharmaceutical and biotechnology companies on marketing strategy and new product development
Selected Tags
Related Tags
Sponsored Links
Top Contributors
Groups interested in oncology
-
cancer - pancreatic
Links specifically related ...
Items: 19 | Visits: 4
Created by: Peter Dearman
-
cancer
Links to information on can...
Items: 89 | Visits: 11
Created by: Peter Dearman
Highlighter, Sticky notes, Tagging, Groups and Network: integrated suite dramatically boosting research productivity. Learn more »
Join Diigo
